Septorinoplasti Planlanan Genç Olguda Anafilaksi

Authors

Halil Cebeci
https://orcid.org/0000-0003-1875-6685
Elif Bengi Şener

Synopsis

This case report details the management of neuromuscular blocker-induced anaphylaxis following anesthesia induction in a 29-year-old ASA I male patient scheduled for septorhinoplasty. The patient, with no underlying medical conditions or known drug allergies, received lidocaine, propofol, and rocuronium bromide during induction. Approximately one minute after endotracheal intubation, the patient suddenly developed a steep increase in peak airway pressure, a sharp drop in end-tidal carbon dioxide, severe hypotension, and tachycardia, which rapidly progressed to cardiac arrest. Cardiopulmonary resuscitation (CPR) was initiated immediately, and spontaneous circulation was restored within two minutes following the administration of 1 mg intravenous epinephrine and rapid fluid bolus. Although no cutaneous manifestations were observed, norepinephrine and hydrocortisone infusions were initiated, the operation was postponed, and the patient was transferred to the intensive care unit intubated. The patient was successfully extubated using sugammadex in the intensive care unit, transferred to the ward the following day, and a skin prick test conducted six weeks later confirmed hypersensitivity to rocuronium bromide. This report underscores that early recognition, immediate epinephrine administration, and effective CPR are life-saving steps when dealing with perioperative anaphylaxis presenting with sudden bronchospasm, severe hypotension, and cardiac arrest.

References

Sacco KA, Gonzalez-Estrada A. An Update on the Management of Anaphylaxis. Current Treatment Options in Allergy, 2018;5(2),212-220.

Takahashi K, Tanaka S, Watanabe M, et al. Rocuronium-induced anaphylaxis: a case report. JA clinical reports, 2019;5(1),1-3.

TUAvKİD. Türkiye Ulusal Alerji ve Klinik İmmünoloji Derneği Dünya Alerji Haftası Basın Bildirisi, 13-19 Haziran 2021 2021]. Available from: https://www.aid.org.tr/dunya-alerji-haftasi-basin-bildirisi-13-19-haziran-2021/.

Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? British journal of anaesthesia, 2001;86(5),678-682.

Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: cardiac arrest in special circumstances. Resuscitation, 2021;161,152-219.

ASCIA. Acute Management of Anaphylaxis: www.allergy.org.au; 2021]. Available from: https://www.allergy.org.au/images/ASCIA_HP_Guidelines_Acute_Management_Anaphylaxis_2021.pdf.

Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation, 2008;77(2),157-169.

Shaker MS, Wallace DV, Golden DB, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Journal of Allergy and Clinical Immunology, 2020;145(4),1082-1123.

Soar J, Maconochie I, Wyckoff MH, et al. 2019 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations: summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces. Circulation, 2019;140(24),e826-e880.

Published

January 13, 2022

License

License